Innovative Treatment Protocols That Can Redefine The Management of nAMD and DR
- Date: Thursday, August 26, 2021
- Time: Registration & Dinner: 6:15 pm – 6:30 pm | CME Activity: 6:30 pm – 7:30 pm
Faculty
Activity Chair: Judy E. Kim, MD
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin,
Milwaukee, WI
Sophie J. Bakri, MD
Professor of Ophthalmology, Mayo Clinic,
Rochester, MN
Learning Objectives:
- Evaluate the evidence from clinical trials on the effectiveness of different treatment regimens in diabetic retinopathy (DR) and age-related macular degeneration (AMD).
- Recognize the role of subretinal and intraretinal fluid on the outcomes of treatment in patients with AMD.
Target Audience: The intended audience for this activity is ophthalmologists, retina specialists, and other health care professionals involved in the management of patients with age-related macular degeneration or diabetic retinopathy.
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Supporter Statement: This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Association Statement: Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.
PRESBYOPIA: EMERGING TREATMENTS OFFER NEW HOPE FOR THE AGING EYE
- Date: Friday, August 27, 2021
- Time: Registration & Breakfast: 6:45 am – 7:00 am | CME Activity: 7:00 am – 8:00 am
FACULTY
Activity Chair: Lisa M. Nijm, MD, JD
Founder, MDNegotiation.com
Founder, RealWorldOphthalmology.com
CEO, Women in Ophthalmology
Founder and Medical Director, Warrenville EyeCare and LASIK
Assistant Clinical Professor of Ophthalmology, University of Illinois Eye and Ear Infirmary,
Chicago, IL
Jennifer M. Loh, MD
Founder, Loh Ophthalmology Associates
Board Member, Eye Physicians of Florida, LLP
Miami, FL
Learning Objectives:
- Describe the benefits, limitations, and risks of current therapeutic options for the treatment of presbyopia.
- Evaluate the efficacy and safety of emerging medical approaches for the treatment of presbyopia that may improve outcomes and patient satisfaction.
Target Audience: The intended audience for the activities is ophthalmologists and other health care professionals involved in the management of patients with presbyopia.
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Supporter Statement: This activity is supported by an educational grant from AbbVie Inc.
Association Statement: Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.
Mitigating Thyroid Eye Disease through Prompt Diagnosis and Treatment
- Date: Friday, August 27, 2021
- Time: Registration & Lunch: 12:15 pm – 12:30 pm | CME Activity: 12:30 pm – 1:30 pm
Faculty:
Activity Chair: Sara Tullis Wester, MD, FACS
Professor of Clinical Ophthalmology
Oculofacial Plastic and Reconstructive Surgery
Orbital Surgery and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine,
Miami, FL
Andrea Lora Kossler, MD, FACS
Director, Oculofacial Plastic & Orbital Surgery
Assistant Professor of Ophthalmology
Stanford University School of Medicine,
Palo Alto, CA
Learning Objectives:
- Review risk factors and classification criteria that aide in the differential diagnosis of thyroid eye disease.
- Examine the use of conventional and new treatments for their ability to improve the overall treatment of thyroid eye disease.
Target Audience: The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with thyroid eye disease.
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Supporter Statement: This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Association Statement: Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.
Futuristic Approaches That Reduce Treatment Burden in AMD and DME
- Date: Saturday, August 28, 2021
- Time: Registration & Lunch: 12:15 pm – 12:30 pm | CME Activity: 12:30 pm – 1:30 pm
Faculty
Activity Chair: Caroline Baumal, MD
Professor of Ophthalmology
New England Eye Center
Tufts University School of Medicine,
Boston, MA
Christina Y. Weng, MD, MBA
Associate Professor of Ophthalmology
Fellowship Program Director, Vitreoretinal Diseases & Surgery
Baylor College of Medicine,
Houston, TX
Learning Objectives:
- Describe the mechanisms behind emerging delivery systems being studied for the treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME).
- Assess new evidence about new therapeutics that can lengthen the time between anti-vascular endothelial growth factor treatments for patients with AMD or DME.
Target Audience: The intended audience for this activity is ophthalmologists, retina specialists, and other health care professionals involved in the management of patients with age-related macular degeneration and diabetic macular edema.
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Supporter Statement: This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Association Statement: Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.
